Organogenesis Holdings Langfristiger Schuldenstrom 2011-2026 | ORGO

Langfristiger Schuldenstrom Jährlich Organogenesis Holdings

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
4.95 M	4.27 M	4.73 M	8.71 M	11.8 M	-	-	-	-	-	-	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
11.8 M	4.27 M	6.89 M

Langfristiger Schuldenstrom anderer Aktien in der Arzneimittelhersteller

Name	Langfristiger Schuldenstrom	Preis	% 24h	Marktkapitalisierung	Land
Endo International plc ENDP	956 K	-	-	$ 28.9 M	Irlanda
Evoke Pharma EVOK	59.5 K	-	-	$ 36.6 M	USA
Cumberland Pharmaceuticals CPIX	468 K	$ 5.6	-	$ 83.2 M	USA
HEXO Corp. HEXO	914 K	-	2.45 %	$ 38.1 M	Canada
Calliditas Therapeutics AB (publ) CALT	12.5 M	-	-0.1 %	$ 2.03 B	Schweden
AcelRx Pharmaceuticals ACRX	100 K	-	7.5 %	$ 6.35 M	USA
DURECT Corporation DRRX	1.08 M	-	-	$ 50.1 M	USA
Adamis Pharmaceuticals Corporation ADMP	343 K	-	0.86 %	$ 117 M	USA
Aerie Pharmaceuticals AERI	4.36 M	-	-	$ 754 M	USA
Agile Therapeutics AGRX	366 K	-	10.11 %	$ 58.2 M	USA
Alimera Sciences ALIM	634 K	-	-	$ 142 M	USA
Cronos Group CRON	337 K	$ 2.66	-0.93 %	$ 1.02 B	Canada
Athenex ATNX	2.09 M	-	-23.39 %	$ 1.76 M	USA
Harrow Health HROW	887 K	$ 39.44	4.78 %	$ 1.45 B	USA
Avadel Pharmaceuticals plc AVDL	582 K	-	-	$ 2.06 B	France
Catalent CTLT	13 M	-	-	$ 11.5 B	USA
Eagle Pharmaceuticals EGRX	1.53 M	-	-39.89 %	$ 27.7 M	USA
Pacira BioSciences PCRX	8.89 M	$ 23.05	0.26 %	$ 1.07 B	USA
Canopy Growth Corporation CGC	7.46 M	$ 1.02	2.0 %	$ 110 M	Canada
Sonoma Pharmaceuticals SNOA	58 K	$ 1.12	2.75 %	$ 1.39 M	USA
Aurora Cannabis ACB	5.38 M	$ 3.13	2.8 %	$ 172 M	Canada
Solid Biosciences SLDB	2.1 M	$ 7.44	4.2 %	$ 651 M	USA
Jupiter Wellness JUPW	23.5 K	-	-	$ 33.6 M	USA
Lannett Company LCI	2.06 M	-	1.15 %	$ 7.11 M	USA
OrganiGram Holdings OGI	1.03 M	$ 1.03	-3.19 %	$ 98.2 M	Canada
Tilray TLRY	2.47 M	$ 5.07	1.71 %	$ 3.13 B	Canada
Evolus EOLS	2.53 M	$ 6.79	0.82 %	$ 438 M	USA
Sundial Growers SNDL	35.5 M	$ 1.44	1.06 %	$ 3.37 M	Canada
Emergent BioSolutions EBS	2.4 M	$ 8.35	0.36 %	$ 447 M	USA
cbdMD YCBD	778 K	$ 0.7	2.06 %	$ 2.82 M	USA
Veru VERU	759 K	$ 3.17	5.5 %	$ 46.4 M	USA
Neoleukin Therapeutics NLTX	3.05 M	-	-	$ 193 M	Canada
Assertio Holdings ASRT	240 K	$ 23.5	0.06 %	$ 150 M	USA
ProPhase Labs PRPH	1.21 M	-	-	$ 5.07 M	USA
Radius Health RDUS	613 K	-	-	$ 1.42 B	USA
Bausch Health Companies BHC	61 M	$ 5.08	0.3 %	$ 1.88 B	Canada
PetIQ PETQ	7.61 M	-	1.64 %	$ 400 M	USA
Recro Pharma REPH	1.1 M	-	-4.76 %	$ 65.3 M	USA
OptiNose OPTN	1.25 M	-	-	$ 1.08 B	USA
SCYNEXIS SCYX	483 K	$ 4.37	3.31 %	$ 218 M	USA
PLx Pharma PLXP	622 K	-	-27.8 %	$ 2.56 M	USA
Viatris VTRS	109 M	$ 16.4	-0.49 %	$ 19.1 B	USA
Zomedica Corp. ZOM	717 K	-	-0.21 %	$ 98 M	USA
Zynerba Pharmaceuticals ZYNE	215 K	-	-	$ 55.5 M	USA
Rockwell Medical RMTI	1.16 M	$ 0.66	5.31 %	$ 23.7 M	USA
Tricida TCDA	2.74 M	-	-	$ 3.25 M	USA
China Pharma Holdings CPHI	71.6 K	$ 0.78	4.82 %	$ 3.35 M	China
TherapeuticsMD TXMD	975 K	$ 2.3	4.32 %	$ 26.6 M	USA